Yves Matthess

934 total citations
17 papers, 643 citations indexed

About

Yves Matthess is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Yves Matthess has authored 17 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Yves Matthess's work include Microtubule and mitosis dynamics (8 papers), Cancer-related Molecular Pathways (7 papers) and Cell death mechanisms and regulation (4 papers). Yves Matthess is often cited by papers focused on Microtubule and mitosis dynamics (8 papers), Cancer-related Molecular Pathways (7 papers) and Cell death mechanisms and regulation (4 papers). Yves Matthess collaborates with scholars based in Germany, United States and Australia. Yves Matthess's co-authors include Klaus Strebhardt, Monika Raab, Mourad Sanhaji, Rainald Knecht, Sven Becker, Manfred Kaufmann, Andrea Krämer, Birgit Spänkuch, Juping Yuan and Inna N. Lavrik and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yves Matthess

16 papers receiving 637 citations

Peers

Yves Matthess

ONCOL

IMMUN

Maider Ibarrola‐Villava Spain

Peng Yue United States

Katja Muehlethaler Switzerland

Nina Goerner Spain

Panagiotis Kotsantis United Kingdom

Weilin Xie United States

Cecilia Grimaldi Italy

Ronald P.C. Wong Canada

Denis G. Bosc Canada

Cheryl McFarlane United Kingdom

Maider Ibarrola‐Villava Spain

Yves Matthess

310 ×0.6

214 ×1.0

ONCOL

185 ×0.9

136 ×1.4

55 ×0.8

IMMUN

Citations per year, relative to Yves Matthess Yves Matthess (= 1×) peers Maider Ibarrola‐Villava

Countries citing papers authored by Yves Matthess

Since Specialization

Citations

This map shows the geographic impact of Yves Matthess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Matthess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Matthess more than expected).

Fields of papers citing papers by Yves Matthess

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Matthess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Matthess. The network helps show where Yves Matthess may publish in the future.

Co-authorship network of co-authors of Yves Matthess

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Matthess. A scholar is included among the top collaborators of Yves Matthess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Matthess. Yves Matthess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Matthess, Yves, et al.. (2025). Multi-scale classification decodes the complexity of the human E3 ligome. Nature Communications. 16(1). 11382–11382.

Wegner, Martin, et al.. (2023). Optimized metrics for orthogonal combinatorial CRISPR screens. Scientific Reports. 13(1). 7405–7405. 4 indexed citations

Raab, Monika, Yves Matthess, Volker Dötsch, et al.. (2021). A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1. Oncogene. 41(3). 372–386. 16 indexed citations

Wegner, Martin, Svenja Wiechmann, Yves Matthess, et al.. (2019). Circular synthesized CRISPR/Cas gRNAs for functional interrogations in the coding and noncoding genome. eLife. 8. 24 indexed citations

Raab, Monika, Mourad Sanhaji, Yves Matthess, et al.. (2018). PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells. Nature Communications. 9(1). 1106–1106. 49 indexed citations

Raab, Monika, Yves Matthess, Mourad Sanhaji, et al.. (2018). Synthetic lethality in CCNE1-amplified high grade serous ovarian cancer through combined inhibition of Polo-like kinase 1 and microtubule dynamics. Oncotarget. 9(40). 25842–25859. 27 indexed citations

Raab, Monika, Franz Rödel, Yves Matthess, et al.. (2016). Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8. Cell Research. 26(8). 914–934. 34 indexed citations

Rödel, Franz, Daniel Martin, Panagiotis Balermpas, et al.. (2016). Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy. Oncotarget. 7(33). 53339–53349. 11 indexed citations

Matthess, Yves, Monika Raab, Rainald Knecht, Sven Becker, & Klaus Strebhardt. (2014). Sequential Cdk1 and Plk1 phosphorylation of caspase‐8 triggers apoptotic cell death during mitosis. Molecular Oncology. 8(3). 596–608. 54 indexed citations

10.

Mandal, Ranadip, Monika Raab, Yves Matthess, et al.. (2013). pERK 1/2 inhibit Caspase‐8 induced apoptosis in cancer cells by phosphorylating it in a cell cycle specific manner. Molecular Oncology. 8(2). 232–249. 46 indexed citations

11.

Raab, Monika, Xin Smith, Yves Matthess, Klaus Strebhardt, & Christopher E. Rudd. (2011). SKAP1 Protein PH Domain Determines RapL Membrane Localization and Rap1 Protein Complex Formation for T Cell Receptor (TCR) Activation of LFA-1. Journal of Biological Chemistry. 286(34). 29663–29670. 35 indexed citations

12.

Matthess, Yves, Monika Raab, Mourad Sanhaji, Inna N. Lavrik, & Klaus Strebhardt. (2010). Cdk1/Cyclin B1 Controls Fas-Mediated Apoptosis by Regulating Caspase-8 Activity. Molecular and Cellular Biology. 30(24). 5726–5740. 82 indexed citations

13.

Kreis, Nina‐Naomi, Katharina Sommer, Mourad Sanhaji, et al.. (2009). Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21^WAF1/CIP1. Cell Cycle. 8(3). 460–472. 52 indexed citations

14.

Matthess, Yves, et al.. (2007). Silencing of mammalian genes by tetracycline-inducible shRNA expression. Nature Protocols. 2(12). 3257–3269. 33 indexed citations

15.

Matthess, Yves, et al.. (2006). Tumor inhibition by genomically integrated inducible RNAi-cassettes. Nucleic Acids Research. 34(16). 4527–4536. 27 indexed citations

16.

Matthess, Yves, et al.. (2005). Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1. Oncogene. 24(18). 2973–2980. 39 indexed citations

17.

Yuan, Juping, Andrea Krämer, Yves Matthess, et al.. (2005). Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo. Oncogene. 25(12). 1753–1762. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact